Federal SB2531 aims to enhance early detection and intervention for uterine fibroids and related gynecological conditions.
Federal SB2531, the Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025, authorizes the Secretary of Health and Human Services to award grants to states. These grants support programs addressing disparities in pain management for uterine fibroid surgical treatment and research on Asherman’s Syndrome and intrauterine adhesions. The bill also mandates the development of evidence-based strategies for early detection of uterine fibroids and requires periodic reports to Congress on funded activities and research findings.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.